| Literature DB >> 26224476 |
David L Kolin1,2, Keiyan Sy3, Fabio Rotondo1, Mena N Bassily4, Kalman Kovacs1, Christine Brezden-Masley5, Catherine J Streutker1,2, George M Yousef6,7,8.
Abstract
Human tissue kallikrein-related peptidases (KLK) are a group of 15 serine proteases which have been investigated as potential cancer biomarkers. This study determined the prognostic significance of KLK 11 and 15 expression levels in gastric carcinoma specimens. Expression of KLK11 and KLK15 was assessed by immunohistochemistry staining on a tissue microarray constructed from 113 gastrectomy specimens from patients with gastric carcinoma. To minimize inter-observer variability, expression levels were quantified using an automated algorithm. Epithelial and stromal staining were assessed separately. Both KLK11 and KLK15 were expressed in gastric carcinoma. There was no significant correlation between either KLK11 or KLK15 expression and the presence of lymph node metastases or Lauren classification (intestinal vs. diffuse). Higher levels of KLK11 expression in gastric carcinoma were associated with significantly worse overall survival (p = 0.008), and a multivariate analysis showed that it had prognostic value independent of tumor stage and differentiation (p = 0.004). Variations in KLK15 expression were not significantly associated with prognosis. KLK11 shows promise as a potential independent prognostic marker for gastric carcinoma.Entities:
Keywords: Gastric cancer; KLK11; KLK15; Kallikreins; Personalized medicine; Tumor markers
Mesh：
Substances：
Year: 2015 PMID： 26224476 DOI： 10.1007/s13277-015-3802-7
Source DB: PubMed Journal: Tumour Biol ISSN： 1010-4283